Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin

Since sodium-glucose cotransporter 2 (SGLT2) inhibitors reduced blood glucose level by inhibiting renal tubular glucose reabsorption mediated by SGLT2, we aimed to investigate the pharmacokinetics and kidney distribution of DWP16001, a novel SGLT2 inhibitor, and to compare these properties with thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Min-Koo, Nam, So Jeong, Ji, Hye-Young, Park, Mi Jie, Choi, Ji-Soo, Song, Im-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151106/
https://www.ncbi.nlm.nih.gov/pubmed/32183468
http://dx.doi.org/10.3390/pharmaceutics12030268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151106/
https://www.ncbi.nlm.nih.gov/pubmed/32183468
http://dx.doi.org/10.3390/pharmaceutics12030268

Ejemplares similares